PIQ — Proteomics International Laboratories Cashflow Statement
0.000.00%
Last trade - 00:00- AU$133.34m
- AU$128.30m
- AU$1.47m
- 42
- 10
- 79
- 42
Annual cashflow statement for Proteomics International Laboratories, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.
2019 June 30th | 2020 June 30th | 2021 June 30th | 2022 June 30th | 2023 June 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Changes in Working Capital | 0.127 | 0.287 | 0.247 | 0.005 | 0.11 |
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -1.67 | -0.385 | -2.21 | -3.54 | -5.69 |
| Capital Expenditures | -0.038 | -1.59 | -0.205 | -0.129 | -1.22 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 0.928 | 0 | 0.014 | 0 | 0.053 |
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Cash from Investing Activities | 0.89 | -1.59 | -0.191 | -0.129 | -1.17 |
| Financing Cash Flow Items | — | — | — | — | -0.063 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -0.029 | 2.82 | 5.64 | 0.176 | 10.8 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -0.805 | 0.854 | 3.24 | -3.49 | 3.92 |